The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

NCT01258816 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Clavis Pharma

Collaborators